Search Results - "Religa, D."

Heart failure and Alzheimer′s disease by Cermakova, P., Eriksdotter, M., Lund, L. H., Winblad, B., Religa, P., Religa, D.

“…It has recently been proposed that heart failure is a risk factor for Alzheimer′s disease. Decreased cerebral blood flow and neurohormonal activation due to…”
Get full text

Sex and gender differences in Alzheimer's disease: current challenges and implications for clinical practice: Position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology by Ferretti, M T, Martinkova, J, Biskup, E, Benke, T, Gialdini, G, Nedelska, Z, Rauen, K, Mantua, V, Religa, D, Hort, J, Santuccione Chadha, A, Schmidt, R

“…Alzheimer's disease (AD) is characterized by high heterogeneity in disease manifestation, progression and risk factors. High phenotypic variability is…”
Get full text

The Association Between the Clinical Frailty Scale and Adverse Health Outcomes in Older Adults in Acute Clinical Settings - A Systematic Review of the Literature by Falk Erhag, Hanna, Guðnadóttir, Gudny, Alfredsson, Joakim, Cederholm, Tommy, Ekerstad, Niklas, Religa, Dorota, Nellgård, Bengt, Wilhelmson, Katarina

“…Frail older adults experience higher rates of adverse health outcomes. Therefore, assessing pre-hospital frailty early in the course of care is essential to…”
Get full text

Heart failure and Alzheimer's disease by Cermakova, P, Eriksdotter, M, Lund, L H, Winblad, B, Religa, P, Religa, D

“…It has recently been proposed that heart failure is a risk factor for Alzheimer's disease. Decreased cerebral blood flow and neurohormonal activation due to…”
Get full text

A European Academy of Neurology guideline on medical management issues in dementia by Frederiksen, K. S., Cooper, C., Frisoni, G. B., Frölich, L., Georges, J., Kramberger, M. G., Nilsson, C., Passmore, P., Mantoan Ritter, L., Religa, D., Schmidt, R., Stefanova, E., Verdelho, Ana, Vandenbulcke, M., Winblad, B., Waldemar, G.

“…© 2020 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. Background and purpose:…”
Get full text

EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia by Sorbi, S., Hort, J., Erkinjuntti, T., Fladby, T., Gainotti, G., Gurvit, H., Nacmias, B., Pasquier, F., Popescu, B. O., Rektorova, I., Religa, D., Rusina, R., Rossor, M., Schmidt, R., Stefanova, E., Warren, J. D., Scheltens, P.

“…Background and objectives The last version of the EFNS dementia guidelines is from 2007. In 2010, the revised guidelines for Alzheimer's disease (AD) were…”
Get full text

SveDem, the Swedish Dementia Registry - a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice by Religa, Dorota, Fereshtehnejad, Seyed-Mohammad, Cermakova, Pavla, Edlund, Ann-Katrin, Garcia-Ptacek, Sara, Granqvist, Nicklas, Hallbäck, Anne, Kåwe, Kerstin, Farahmand, Bahman, Kilander, Lena, Mattsson, Ulla-Britt, Nägga, Katarina, Nordström, Peter, Wijk, Helle, Wimo, Anders, Winblad, Bengt, Eriksdotter, Maria

“…The Swedish Dementia Registry (SveDem) was developed with the aim to improve the quality of diagnostic work-up, treatment and care of patients with dementia…”
Get full text

Body mass index and Mini Nutritional Assessment-Short Form as predictors of in-geriatric hospital mortality in older adults with COVID-19 by Kananen, L., Eriksdotter, M., Boström, A.M., Kivipelto, M., Annetorp, M., Metzner, C., Bäck Jerlardtz, V., Engström, M., Johnson, P., Lundberg, L.G., Åkesson, E., Sühl Öberg, C., Hägg, S., Religa, D., Jylhävä, J., Cederholm, T.

“…Overweight and obesity have been consistently reported to carry an increased risk for poorer outcomes in coronavirus disease 2019 (COVID-19) in adults…”
Get full text

EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease by Schmidt, R., Hofer, E., Bouwman, F. H., Buerger, K., Cordonnier, C., Fladby, T., Galimberti, D., Georges, J., Heneka, M. T., Hort, J., Laczó, J., Molinuevo, J. L, O'Brien, J. T., Religa, D., Scheltens, P., Schott, J. M., Sorbi, S.

“…Background and purpose Previous studies have indicated clinical benefits of a combination of cholinesterase inhibitors (ChEI) and memantine over ChEI…”
Get full text

Red blood cell distribution width is associated with increased interactions of blood cells with vascular wall by Ananthaseshan, Sharan, Bojakowski, Krzysztof, Sacharczuk, Mariusz, Poznanski, Piotr, Skiba, Dominik S., Prahl Wittberg, Lisa, McKenzie, Jordan, Szkulmowska, Anna, Berg, Niclas, Andziak, Piotr, Menkens, Hanna, Wojtkowski, Maciej, Religa, Dorota, Lundell, Fredrik, Guzik, Tomasz, Gaciong, Zbigniew, Religa, Piotr

“…The mechanism underlying the association between elevated red cell distribution width (RDW) and poor prognosis in variety of diseases is unknown although many…”
Get full text

Body mass index in dementia by García-Ptacek, S, Faxén-Irving, G, Čermáková, P, Eriksdotter, M, Religa, D

“…This review comprehensively examines the current knowledge on the relationship between body mass index (BMI) and dementia. The association between BMI and…”
Get full text

Elevated cortical zinc in Alzheimer disease by RELIGA, D, STROZYK, D, CHERNY, R. A, VOLITAKIS, I, HAROUTUNIAN, V, WINBLAD, B, NASLUND, J, BUSH, A. I

“…To determine whether changes in brain biometals in Alzheimer disease (AD) and in normal brain tissue are tandemly associated with amyloid beta-peptide (Abeta)…”
Get full text

Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry by Enache, D., Fereshtehnejad, S.-M., Kåreholt, I., Cermakova, P., Garcia-Ptacek, S., Johnell, K., Religa, D., Jelic, V., Winblad, B., Ballard, C., Aarsland, D., Fastbom, J., Eriksdotter, M.

“…Background The association between mortality risk and use of antidepressants in people with dementia is unknown. Objective To describe the use of…”
Get full text

Use of Electronic Medical Records (EMR) in Gerontology: Benefits, Considerations and a Promising Future by Bednorz, Adam, Mak, Jonathan K L, Jylhävä, Juulia, Religa, Dorota

“…Electronic medical records (EMRs) have many benefits in clinical research in gerontology, enabling data analysis, development of prognostic tools and disease…”
Get full text

Sex and gender differences in Alzheimer’s disease: current challenges and implications for clinical practice by Ferretti, M. T., Martinkova, J., Biskup, E., Benke, T., Gialdini, G., Nedelska, Z., Rauen, K., Mantua, V., Religa, D., Hort, J., Santuccione Chadha, A., Schmidt, R.

“…Alzheimer’s disease (AD) is characterized by high heterogeneity in disease manifestation, progression and risk factors. High phenotypic variability is…”
Get full text

Influence of Education and Income on Receipt of Dementia Care in Sweden by Hoang, Minh Tuan, Kåreholt, Ingemar, von Koch, Lena, Xu, Hong, Secnik, Juraj, Religa, Dorota, Tan, Edwin C.K., Johnell, Kristina, Garcia-Ptacek, Sara

“…To explore the dementia diagnostic process and drug prescription for persons with dementia (PWD) with different socioeconomic status (SES). Register-based…”
Get full text

The Effect of Xerostomic Medication on Oral Health in Persons With Dementia by Lexomboon, Duangjai, Tan, Edwin CK, Höijer, Jonas, Garcia-Ptacek, Sara, Eriksdotter, Maria, Religa, Dorota, Fastbom, Johan, Johnell, Kristina, Sandborgh-Englund, Gunilla

“…Medication-induced hyposalivation can increase the risk for oral complications, including dental caries and tooth loss. This problem is particularly important…”
Get full text

A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene by Sitek, Emilia J, Narożańska, Ewa, Pepłońska, Beata, Filipek, Sławomir, Barczak, Anna, Styczyńska, Maria, Mlynarczyk, Krzysztof, Brockhuis, Bogna, Portelius, Erik, Religa, Dorota, Barcikowska, Maria, Sławek, Jarosław, Żekanowski, Cezary

“…Posterior cortical atrophy is a dementia syndrome with symptoms of cortical visual dysfunction, associated with amyloid plaques and neurofibrillary tangles…”
Get full text

Svedem, the Swedish dementia registry – A tool for improving the quality of diagnostics, treatment and care by Religa, D, Winblad, B, Cermakova, P, Fereshtehnejad, M, Garcia Ptacek, S, Eriksdotter, M

Get full text

Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease by Religa, D., Czyzewski, K., Styczynska, M., Peplonska, B., Lokk, J., Chodakowska-Zebrowska, M., Stepien, K., Winblad, B., Barcikowska, M.

“…Elevated levels of homocysteine have been observed in Parkinson's disease (PD) patients treated with levodopa. However, it is not studied if duration of PD or…”
Get full text